TNF Pharmaceuticals, Inc. (LON: 0A8D)

TNF Pharmaceuticals Statistics

Total Valuation

TNF Pharmaceuticals has a market cap or net worth of GBP 1.95 million. The enterprise value is -6.26 million.

Market Cap	1.95M
Enterprise Value	-6.26M

Important Dates

The next estimated earnings date is Thursday, April 3, 2025.

Earnings Date	Apr 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+52.29%
Shares Change (QoQ)	+6.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.29
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.00.

Current Ratio	1.72
Quick Ratio	1.52
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -142.68% and return on invested capital (ROIC) is -42.75%.

Return on Equity (ROE)	-142.68%
Return on Assets (ROA)	-31.01%
Return on Invested Capital (ROIC)	-42.75%
Return on Capital Employed (ROCE)	-66.72%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-81.70%
50-Day Moving Average	1.26
200-Day Moving Average	4.49
Relative Strength Index (RSI)	36.25
Average Volume (20 Days)	1,970

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.96

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.49M
Pretax Income	-17.65M
Net Income	-21.57M
EBITDA	n/a
EBIT	-8.49M
Earnings Per Share (EPS)	-9.96

Balance Sheet

The company has 7.94 million in cash and 13,642 in debt, giving a net cash position of 7.93 million.

Cash & Cash Equivalents	7.94M
Total Debt	13,642
Net Cash	7.93M
Net Cash Per Share	n/a
Equity (Book Value)	12.72M
Book Value Per Share	5.02
Working Capital	3.76M

Cash Flow

Operating Cash Flow	-7.57M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TNF Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-52.29%
Shareholder Yield	-52.29%
Earnings Yield	-1,106.00%
FCF Yield	n/a

Stock Splits

The last stock split was on February 15, 2024. It was a reverse split with a ratio of 0.0333333333.

Last Split Date	Feb 15, 2024
Split Type	Reverse
Split Ratio	0.0333333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a